A recent study by Yan and his colleagues in 2021 shed light on this aspect, demonstrating heightened expression levels of HA, hyaluronic acid synthase 3 (HAS3), and the HA receptor CD44 correlated inversely with the prognosis of glioma patients [45]. This evidence concerns the gene HAS3 and glioma.